Analogous involvement of the citrate pathway was found in Down syndrome, where hydroxycitrate—a natural ACLY inhibitor—reduced the typical prooxidant status, but the addition of malate or NADPH abolished its antioxidant effect [19]. The gene discussed is ACLY; the disease is Down syndrome.